Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer
نویسندگان
چکیده
منابع مشابه
Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients
The aim of the study was to investigate the prognostic significance of selected risk assessment models (RAMs) for predicting venous thromboembolism (VTE) events in patients undergoing outpatient chemotherapy for lung cancer. We evaluated the following VTE-risk assessment tools: Khorana risk score (KRS), PROTECHT score, CONKO score and COMPASS-cancer-associated thrombosis score (COMPASS-CAT). Re...
متن کاملAnticoagulation for venous thromboembolism
Acute venous thromboembolism (VTE) is treated with parenteral administration of heparin or derivatives, in conjunction with oral vitamin K antagonists (VKAs) to reach and maintain INR values between 2.0 and 3.0 for at least 3 months; the duration of a further period of treatment for secondary prevention of recurrences is still matter of debate. If bleeding occurs during treatment the decision w...
متن کاملApplication of the Caprini risk assessment model in evaluation of non-venous thromboembolism complications in plastic and reconstructive surgery patients.
BACKGROUND The Caprini Risk Assessment Model is used to categorize patient risk for venous thromboembolism (VTE) events; its predictive associations have been repeatedly corroborated. Calculating scores involves consideration of systemic factors that may predict other postoperative complications. OBJECTIVE This study investigates whether Caprini scores can be applied to non-VTE complications....
متن کاملAnticoagulation after venous thromboembolism
Deep vein thrombosis and pulmonary embolism are two manifestations of the same disease, namely venous thromboembolism (VTE). Venous thromboembolism is a common disease with an annual incidence of 1–2 per 1000 person and a high short-term mortality rate of about 25% (1–3). A serious complication of VTE is recurrence, which is fatal in 3.6% to 10% of patients (4–6). In the majority of the patient...
متن کاملOptimal duration of anticoagulation in patients with venous thromboembolism
The risk of recurrent venous thromboembolism (VTE) approaches 40 per cent of all patients after 10 yr of follow up. This risk is higher in patients with permanent risk factors of thrombosis such as active cancer, prolonged immobilization from medical diseases, and antiphospholipid syndrome; in carriers of several thrombophilic abnormalities, including deficiencies of natural anticoagulants; and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Thoracic and Cardiovascular Surgery
سال: 2016
ISSN: 0022-5223
DOI: 10.1016/j.jtcvs.2015.08.039